• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

India May Be Nearing Dispute Settlement With EU Over Generic Drug Seizures

28/08/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment

Ongoing concerns in India that their legitimate generic drug shipments are being delayed as potential counterfeits while in transit through Europe may reach the dispute settlement body at the World Trade Organization, according to sources.

Filed Under: Features, IP Policies, Language, Themes, Venues, Copyright Policy, English, Health & IP, IP Law, Patents/Designs/Trade Secrets, WTO/TRIPS

Indian High Court Rejects Bayer Complaint For Patent Linkage

21/08/2009 by Monika Ermert for Intellectual Property Watch and Kaitlin Mara for Intellectual Property Watch 3 Comments

Indian generics manufacturer Cipla can get marketing approval for its generic cancer treatment Soranib, the Delhi High Court ruled Tuesday, and the Indian drug regulatory authority does not have to check its patent status first. The court this week rejected a complaint by drug multinational Bayer against the Union of India, the Drug Controller General of India and generic drug producer Cipla.

Bayer sought a court order requiring DCGI to consider the patent status of kidney cancer drug, sorafenib tosylate (sold under the brand name Nexavar), before granting marketing approval for a generic version of the drug.

At issue was whether it is legitimate to link a potential violation of IP rights to processes regulating a drug’s entry onto the market that are generally based on drug quality, efficacy and safety.

Filed Under: IP Policies, Language, News, Themes, Venues, Asia/Pacific, English, Health & IP, IP Law, Patents/Designs/Trade Secrets, WTO/TRIPS

Law Professors Debate Bilski

19/08/2009 by Intellectual Property Watch Leave a Comment

A potentially paradigm-shifting legal case that could restrict the granting of business method patents in the United States, Bilski v. Doll has attracted the attention of policy makers world-wide, who expect its outcome to influence the international patent system (IPW, US Policy, 31 July 2009). At issue in the case is whether or not a […]

Filed Under: IP-Watch Briefs, English

Members Of Human Rights Expert Committee At UN Question Patents On Food

07/08/2009 by Kaitlin Mara for Intellectual Property Watch 7 Comments

A group of experts working as a think-tank for the United Nations Human Rights Council raised the issue of patents and food at a meeting this week. Meanwhile, a new report by the UN Special Rapporteur on the Right to Food expected to be available at the end of August will focus on the intersection between intellectual property and the human right to food.

Filed Under: Features, IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Development, English, Human Rights, Patents/Designs/Trade Secrets, United Nations - other

Congress Members Seek Permanent ICANN-US Link

05/08/2009 by Intellectual Property Watch 1 Comment

A group of US congressional members have sent a letter to US Commerce Secretary Gary Locke calling for a temporary arrangement between the Department of Commerce (DOC) and the Internet Corporation for Assigned Names and Numbers (which manages technical aspects of the internet domain name system) to be made permanent. The joint project agreement between […]

Filed Under: IP-Watch Briefs, Language, Venues, English, ITU/ICANN, North America

IP Dispute Could Threaten Skype

01/08/2009 by Intellectual Property Watch Leave a Comment

Online auction site eBay, the owner of popular, proprietary voice-over-internet protocol software Skype, has warned that the service might not continue if it loses an intellectual property dispute with Joltid, the company from which it licences Skype’s core technology. “If Skype was to lose the right to use the Joltid software as the result of […]

Filed Under: IP-Watch Briefs, English

Proponents Fight To Keep IP Issues At High Level At WTO

30/07/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment

With governments looking to close the long-stalled Doha Round of trade liberalisation talks in 2010, what will happen to remaining disagreements on intellectual property issues is still unclear. But proponents of amending the World Trade Organization intellectual property agreement reasserted the need to have them addressed.

Filed Under: IP Policies, Language, News, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Patents/Designs/Trade Secrets, Traditional and Indigenous Knowledge, WTO/TRIPS

Rumoured New US Ambassador To UN In Geneva A Major Obama Fundraiser

29/07/2009 by Kaitlin Mara for Intellectual Property Watch and William New 1 Comment

A Northern California academic and a top national fundraiser for President Obama may be the next US ambassador to the United Nations in Geneva, according to sources. Eileen Chamberlain Donahoe, wife of eBay CEO and President John Donahoe, holds a law degree, two master’s degrees and a PhD in a variety of subjects, and is rumoured to be the nominee for the post empty since January.

Filed Under: Language, News, Venues, English, North America

Being Sued By The RIAA

28/07/2009 by Intellectual Property Watch Leave a Comment

Joel Tenenbaum, who is involved in a high-profile challenge of the music industry’s suit against him on the charge of unauthorised sharing of music, has written an editorial about his experiences of intimidation tactics. It is available from the Guardian here. His case is profiled here (IPW, Copyright, 7 April 2009).

Filed Under: IP-Watch Briefs, English

Academics Debate How To Release ‘Revolutionary’ Power Of Development Agenda

28/07/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment

The Development Agenda at the World Intellectual Property Organization is a “potentially revolutionary” agreement, according to a book released this month, but whether it will fulfil that promise depends on its implementation into concrete practice, said a panel of academics at the book’s launch.

Filed Under: Features, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, Development, English, Innovation/ R&D, Patents/Designs/Trade Secrets, WIPO

  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 48
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting